| 2024-06-13 | Sale | uniQure N.V. QURE | director | 2,231 0.0045% | $5.12 | $11,423 | -12.95% | |
| 2023-06-16 | Sale | uniQure N.V. QURE | director | 2,286 0.0047% | $18.88 | $43,160 | -67.56% | |
| 2023-02-27 | Sale | uniQure N.V. QURE | director | 384 0.0008% | $20.41 | $7,837 | -59.21% | |
| 2022-02-28 | Sale | uniQure N.V. QURE | director | 602 0.0013% | $16.70 | $10,053 | +15.01% | |
| 2021-03-02 | Sale | uniQure N.V. QURE | director | 505 0.0012% | $37.50 | $18,938 | -16.12% | |
| 2020-01-28 | Sale | uniQure N.V. QURE | director | 1,614 0.0037% | $62.19 | $100,381 | -27.28% | |
| 2019-11-12 | Syros Pharmaceuticals, Inc. SYRS | Chief Business Officer | 10,121 0.0249% | $4.97 | $50,268 | +68.53% | ||
| 2019-11-11 | Syros Pharmaceuticals, Inc. SYRS | Chief Business Officer | 9,879 0.0246% | $4.99 | $49,328 | +69.34% | ||
| 2019-01-28 | Sale | uniQure N.V. QURE | director | 2,420 0.0063% | $31.32 | $75,794 | +82.93% | |
| 2017-12-15 | Syros Pharmaceuticals, Inc. SYRS | Chief Business Officer | 15,000 0.0576% | $9.08 | $136,260 | +22.91% |